X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (317) 317
Publication (29) 29
Book / eBook (3) 3
Newspaper Article (3) 3
Book Review (2) 2
Book Chapter (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (156) 156
female (118) 118
male (109) 109
adult (104) 104
middle aged (95) 95
index medicus (93) 93
aged (67) 67
medicine, general & internal (48) 48
rheumatology (40) 40
retrospective studies (35) 35
treatment outcome (35) 35
abridged index medicus (32) 32
adolescent (30) 30
diagnosis (30) 30
aged, 80 and over (29) 29
life sciences (22) 22
young adult (22) 22
risk factors (21) 21
immunosuppressive agents - therapeutic use (20) 20
analysis (19) 19
care and treatment (18) 18
lupus (18) 18
disease (17) 17
follow-up studies (17) 17
health aspects (17) 17
immunology (17) 17
systemic lupus erythematosus (16) 16
diagnosis, differential (15) 15
drug therapy, combination (14) 14
france (14) 14
classification (13) 13
hematology (13) 13
magnetic resonance imaging (13) 13
management (13) 13
patients (12) 12
therapy (12) 12
biopsy (11) 11
recurrence (11) 11
animals (10) 10
child (10) 10
cohort studies (10) 10
criteria (10) 10
france - epidemiology (10) 10
involvement (10) 10
medical research (10) 10
patient (10) 10
prednisone - therapeutic use (10) 10
prospective studies (10) 10
research (10) 10
thrombosis (10) 10
[ sdv ] life sciences [q-bio] (9) 9
[sdv]life sciences [q-bio] (9) 9
drug therapy (9) 9
glucocorticoids - therapeutic use (9) 9
prognosis (9) 9
respiratory system (9) 9
tomography, x-ray computed (9) 9
vasculitis (9) 9
cardiac & cardiovascular systems (8) 8
case studies (8) 8
chronic disease (8) 8
clinical neurology (8) 8
cyclophosphamide - therapeutic use (8) 8
internal medicine (8) 8
lupus erythematosus, systemic - complications (8) 8
lupus erythematosus, systemic - immunology (8) 8
mortality (8) 8
patient outcomes (8) 8
risk (8) 8
severity of illness index (8) 8
usage (8) 8
vaccination (8) 8
adrenal cortex hormones - therapeutic use (7) 7
autoimmune diseases (7) 7
causes of (7) 7
complications and side effects (7) 7
critical care medicine (7) 7
inflammation (7) 7
medicine, experimental (7) 7
mice (7) 7
multidisciplinary sciences (7) 7
nephritis (7) 7
of-the-literature (7) 7
predictive value of tests (7) 7
research article (7) 7
rituximab (7) 7
skin and connective tissue diseases (7) 7
steroids - therapeutic use (7) 7
acute disease (6) 6
allergy and immunology (6) 6
case-control studies (6) 6
complications (6) 6
dosage and administration (6) 6
efficacy (6) 6
immunoglobulins (6) 6
manifestations (6) 6
observational study (6) 6
physiological aspects (6) 6
proteins (6) 6
remission induction (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2014, Volume 371, Issue 19, pp. 1771 - 1780
Journal Article
Revue du Rhumatisme (Edition Francaise), ISSN 1169-8330, 2004, Volume 71, Issue 3, pp. 259 - 260
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 11/2017, Volume 69, Issue 11, pp. 2175 - 2186
Objective In most patients with nonsevere systemic necrotizing vasculitides (SNVs), remission is achieved with glucocorticoids alone, but one‐third experience... 
Glucocorticoids | Rhinosinusitis | Leukocytes (eosinophilic) | Granulomatosis | Patients | Placebo effect | Asthma | Randomization | Remission | Azathioprine | Failure | Steroid hormones | Steroids | Life Sciences | Human health and pathology | Rhumatology and musculoskeletal system
Journal Article
Journal Article
Rheumatology, ISSN 1462-0324, 03/2019, Volume 58, Issue Supplement_2
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 06/2014, Volume 66, Issue 6, pp. 1672 - 1677
Objective Infective endocarditis (IE) mimics primary systemic vasculitis, and there are sporadic reports of positivity for antineutrophil cytoplasmic... 
Rheumatoid Factor - blood | Endocarditis - blood | Prospective Studies | Immunoglobulin G - blood | Humans | Middle Aged | Male | Seroepidemiologic Studies | Endocarditis - immunology | Antibodies, Antinuclear - blood | Adult | Female | Aged | Antibodies, Antineutrophil Cytoplasmic - blood | Cohort Studies | Health risk assessment | Immunoglobulins
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2008, Volume 359, Issue 26, pp. 2790 - 2803
Current standard therapy for Wegener's granulomatosis and microscopic polyangiitis combines corticosteroids and cyclophosphamide to induce remission, followed... 
WEGENERS-GRANULOMATOSIS | RHEUMATOID-ARTHRITIS | MEDICINE, GENERAL & INTERNAL | CHURG-STRAUSS-SYNDROME | SYSTEMIC VASCULITIS | ANTIBODY-ASSOCIATED VASCULITIS | ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES | RANDOMIZED-TRIAL | FOLLOW-UP | POLYARTERITIS-NODOSA | PULSE CYCLOPHOSPHAMIDE | Azathioprine - therapeutic use | Cyclophosphamide - administration & dosage | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Prospective Studies | Methylprednisolone - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Methotrexate - therapeutic use | Cyclophosphamide - therapeutic use | Vasculitis - immunology | Young Adult | Antibodies, Antineutrophil Cytoplasmic | Granulomatosis with Polyangiitis - immunology | Adult | Female | Drug Therapy, Combination | Immunosuppressive Agents - administration & dosage | Prednisone - administration & dosage | Kaplan-Meier Estimate | Pulse Therapy, Drug | Remission Induction | Methotrexate - adverse effects | Vasculitis - drug therapy | Granulomatosis with Polyangiitis - drug therapy | Immunosuppressive Agents - adverse effects | Aged | Azathioprine - adverse effects | Prednisone - therapeutic use | Methylprednisolone - administration & dosage | Complications and side effects | Usage | Azathioprine | Methotrexate | Health aspects | Clinical trials | Medical research | Index Medicus | Abridged Index Medicus
Journal Article
Chest, ISSN 0012-3692, 2015, Volume 148, Issue 4, pp. 927 - 935
BACKGROUND Patients with systemic rheumatic diseases (SRDs) may require ICU management for SRD exacerbation or treatment-related infections or toxicities.... 
Pulmonary/Respiratory
Journal Article
by Carmona, F. David and Vaglio, Augusto and Mackie, Sarah L and Hernández-Rodríguez, José and Monach, Paul A and Castañeda, Santos and Solans, Roser and Morado, Inmaculada C and Narváez, Javier and Ramentol-Sintas, Marc and Pease, Colin T and Dasgupta, Bhaskar and Watts, Richard and Khalidi, Nader and Langford, Carol A and Ytterberg, Steven and Boiardi, Luigi and Beretta, Lorenzo and Govoni, Marcello and Emmi, Giacomo and Bonatti, Francesco and Cimmino, Marco A and Witte, Torsten and Neumann, Thomas and Holle, Julia and Schönau, Verena and Sailler, Laurent and Papo, Thomas and Haroche, Julien and Mahr, Alfred and Mouthon, Luc and Molberg, Øyvind and Diamantopoulos, Andreas P and Voskuyl, Alexandre and Brouwer, Elisabeth and Daikeler, Thomas and Berger, Christoph T and Molloy, Eamonn S and O’Neill, Lorraine and Blockmans, Daniel and Lie, Benedicte A and Mclaren, Paul and Vyse, Timothy J and Wijmenga, Cisca and Allanore, Yannick and Koeleman, Bobby P.C and Callejas, José Luis and Caminal-Montero, Luis and Corbera-Bellalta, Marc and de Miguel, Eugenio and López, J. Bernardino Díaz and García-Villanueva, María Jesús and Gómez-Vaquero, Carmen and Guijarro-Rojas, Mercedes and Hidalgo-Conde, Ana and Marí-Alfonso, Begoña and Berriochoa, Agustín Martínez and Zapico, Aleida Martínez and Martínez-Taboada, Víctor Manuel and Miranda-Filloy, José A and Monfort, Jordi and Ortego-Centeno, Norberto and Pérez-Conesa, Mercedes and Prieto-González, Sergio and Raya, Enrique and Fernández, Raquel Ríos and Sánchez-Martín, Julio and Sopeña, Bernardo and Tío, Laura and Unzurrunzaga, Ainhoa and Gough, Andrew and Isaacs, John D and Green, Michael and McHugh, Neil and Hordon, Lesley and Kamath, Sanjeet and Nisar, Mohammed and Patel, Yusuf and Yee, Cee-Seng and Stevens, Robert and Nandi, Pradip and Nandagudi, Anupama and Jarrett, Stephen and Li, Charles and Levy, Sarah and Mollan, Susan and Salih, Abdel and Wordsworth, Oliver and Sanders, Emma and Roads, Esme and Gill, Anne and Carr, Lisa and Routledge, Christine and Culfear, Karen and Nugaliyadde, Asanka and James, Lynne and Spimpolo, Jenny and Kempa, Andy and Mackenzie, Felicity and Fong, Rosanna and ... and Vasculitis Clinical Res Consortium and UKGCA Consortium and Spanish CGA Grp and Vasculitis Clinical Research Consortium and Spanish CGA Group
The American Journal of Human Genetics, ISSN 0002-9297, 01/2017, Volume 100, Issue 1, pp. 64 - 74
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2014, Volume 9, Issue 4, p. e94511
Cardiovascular disease (CVD) is a major cause of death in systemic lupus erythematosus (SLE) patients. Although the risk for cardiovascular events in patients... 
CRITERIA | WOMEN | CLASSIFICATION | PULSE-WAVE VELOCITY | ACCELERATED ATHEROSCLEROSIS | MULTIDISCIPLINARY SCIENCES | Blood Pressure | Cardiovascular Diseases - etiology | Cardiovascular Diseases - physiopathology | Glucocorticoids - therapeutic use | Lupus Erythematosus, Systemic - complications | Prospective Studies | Cross-Sectional Studies | Pulse Wave Analysis | Carotid Intima-Media Thickness | Cardiovascular Diseases - drug therapy | Femoral Artery - physiopathology | Humans | Middle Aged | Risk Factors | Logistic Models | Male | Case-Control Studies | Carotid Arteries - physiopathology | Lupus Erythematosus, Systemic - drug therapy | Adult | Female | Lupus Erythematosus, Systemic - physiopathology | Vascular Stiffness | Complications and side effects | Care and treatment | Corticosteroids | Systemic lupus erythematosus | Patient outcomes | Atherosclerosis | Genetic aspects | Research | Health aspects | Risk factors | Statins | Femur | Glucocorticoids | Correlation coefficients | Elasticity | Cytotoxicity | Cardiovascular disease | Lymphocytes T | Multivariate analysis | Blood | Arteries | Regression models | Stiffness | Blood pressure | Lupus | Correlation coefficient | Health risks | Regression analysis | Wall thickness | Risk analysis | Disease control | Patients | Velocity | Chronic conditions | Correlation analysis | Arteriosclerosis | Wave velocity | Cardiovascular diseases | Autoimmune diseases | Health risk assessment | Life Sciences | Santé publique et épidémiologie
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2017, Volume 130, Issue 10, pp. 1219.e19 - 1219.e27
Journal Article